Feingold Jay 4
4 · Pyxis Oncology, Inc. · Filed Oct 12, 2021
Insider Transaction Report
Form 4
Feingold Jay
Chief Medical Officer
Transactions
- Award
Stock Option (Right to buy)
2021-10-07+436,929→ 436,929 totalExercise: $16.00Exp: 2031-10-07→ Common Stock (436,929 underlying) - Award
Common Stock
2021-10-07+43,750→ 43,750 total
Footnotes (2)
- [F1]Represents shares of restricted stock that vest 25% of the first anniversary of September 13, 2021, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
- [F2]These stock options vest 25% on the first anniversary of September 13, 2021, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.